Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -2.74% shed 2.84% to $77.21 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -1.57% falling 2.28% to 13,539.29 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.14% falling 0.19% to 34,297.73. This was the stock's 10th consecutive day of losses. Novavax Inc. closed $254.47 below its 52-week high ($331.68), which the company achieved on February 9th.
The stock underperformed when compared to some of its competitors Tuesday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL -1.18% fell 2.36% to $20.70, VBI Vaccines Inc. /zigman2/quotes/201705917/composite VBIV +2.59% fell 0.57% to $1.73, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB +4.73% rose 0.06% to $32.50. Trading volume (7.5 M) eclipsed its 50-day average volume of 6.1 M.